Last reviewed · How we verify
Recombinant EphB4-HSA Fusion Protein
Recombinant EphB4-HSA Fusion Protein is a Biologic drug developed by AIDS Malignancy Consortium. It is currently in Phase 2 development. Also known as: sEphB4-HSA.
At a glance
| Generic name | Recombinant EphB4-HSA Fusion Protein |
|---|---|
| Also known as | sEphB4-HSA |
| Sponsor | AIDS Malignancy Consortium |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (PHASE1)
- Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 (PHASE2)
- Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors (PHASE2)
- sEphB4-HSA in Treating Patients With Kaposi Sarcoma (PHASE2)
- Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors (PHASE2, PHASE3)
- sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC (PHASE1)
- A Study of sEphB4-HSA in Kaposi Sarcoma (PHASE2)
- A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Recombinant EphB4-HSA Fusion Protein CI brief — competitive landscape report
- Recombinant EphB4-HSA Fusion Protein updates RSS · CI watch RSS
- AIDS Malignancy Consortium portfolio CI
Frequently asked questions about Recombinant EphB4-HSA Fusion Protein
What is Recombinant EphB4-HSA Fusion Protein?
Recombinant EphB4-HSA Fusion Protein is a Biologic drug developed by AIDS Malignancy Consortium.
Who makes Recombinant EphB4-HSA Fusion Protein?
Recombinant EphB4-HSA Fusion Protein is developed by AIDS Malignancy Consortium (see full AIDS Malignancy Consortium pipeline at /company/aids-malignancy-consortium).
Is Recombinant EphB4-HSA Fusion Protein also known as anything else?
Recombinant EphB4-HSA Fusion Protein is also known as sEphB4-HSA.
What development phase is Recombinant EphB4-HSA Fusion Protein in?
Recombinant EphB4-HSA Fusion Protein is in Phase 2.
Related
- Manufacturer: AIDS Malignancy Consortium — full pipeline
- Also known as: sEphB4-HSA
- Compare: Recombinant EphB4-HSA Fusion Protein vs similar drugs
- Pricing: Recombinant EphB4-HSA Fusion Protein cost, discount & access